|
2021
|
Invention
|
Filovirus vaccines and methods of use.
The data reported herein describe the production and eval... |
|
|
Invention
|
Recombinant sars-cov-2 spike protein subunits, expression and uses thereof.
The present inventio... |
|
|
Invention
|
Recombinant sars-cov-2 spike protein subunits, expression and uses thereof. The present invention... |
|
2020
|
P/S
|
Pharmaceuticals for the treatment of eliminating toxins and inflamatory, infectious, and neurolog... |
|
|
Invention
|
Hydroxamic acids comprising pyrazole moiety and uses thereof. Compounds of Formula I are provided... |
|
2019
|
Invention
|
Pyridin-2-yl alkylamino substituted hydroxamic acid and uses thereof. Compounds of formula I are ... |
|
|
Invention
|
Pyridin-2-yl alkylamino substituted hydroxamic acid and uses thereof. 25114 1422'141431414414144 ... |
|
2018
|
Invention
|
Filovirus vaccine and methods of use. The data reported herein describe the production and evalua... |
|
2017
|
Invention
|
Optimized zika virus envelope gene and expression thereof. The present invention is directed to t... |
|
|
Invention
|
West nile virus vaccine and method of use thereof. A West Nile virus (WNV) vaccine for human use ... |
|
2016
|
Invention
|
West nile virus vaccine comprising wn-80e recombinant subunit protein. A West Nile virus vaccine ... |
|
|
Invention
|
Hydroxamic acids and uses thereof. Compounds of formula I are provided:
3 is not hydrogen.
|
|
|
Invention
|
Hydroxamic acids and uses thereof. Compounds of formula I are provided Formula (I) R1 is an alkox... |
|
2010
|
Invention
|
Enhanced malaria msp-1 subunit vaccine. Recombinant subunit proteins derived from the MSP-1 C-ter... |
|
|
Invention
|
Recombinant subunit west nile virus vaccine for protection of human subjects.
A West Nile virus ... |
|
|
Invention
|
Recombinant subunit west nile virus vaccine for protections of human subjects. A West Nile virus ... |
|
2008
|
Invention
|
Synthetic expression vectors for insect cells. The present invention is directed at optimized exp... |
|
2006
|
Invention
|
Recombinant proteins from filoviruses and their use. Filovirus subunit protein immunogens are pro... |
|
|
Invention
|
Influenza recombinant subunit vaccine.
The invention provides influenza proteins, including subu... |
|
|
Invention
|
Influenza recombinant subunit vaccine. The invention provides influenza proteins, including subun... |
|
|
Invention
|
Malaria msp-1 c-terminal enhanced subunit vaccine. A vaccine or immunogenic composition is descri... |
|
|
Invention
|
Malaria msp-1 c-terminal enhanced subunit vaccine.
A vaccine or immunogenic composition is descr... |
|
2005
|
Invention
|
Subunit vaccine against west nile viral infection. An immunogenic composition is described that p... |
|
|
Invention
|
Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid ... |
|
|
Invention
|
Subunit vaccine against west nile viral infection.
An immunogenic composition is described that ... |
|
|
Invention
|
Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation. A method f... |
|
2004
|
Invention
|
Treatment of anthrax infection using inhibitors of lethal factor protease activity. Compounds con... |
|
2003
|
Invention
|
Recombinant vaccine against flavivirus infection. An immunogenic composition is described which p... |
|
|
Invention
|
Structural carotenoid analogs for the inhibition and amelioration of disease. A method for inhibi... |
|
2002
|
Invention
|
Recombinant dimeric envelope vaccine against flaviviral infection. The present invention disclose... |
